Convergent Science Physical Oncology (CSPO) has named Professor Robert Ivkov, from Johns Hopkins University School of Medicine, as its new Editor-in-Chief.
As Associate Professor of Radiation Oncology and Molecular Radiation Sciences at Johns Hopkins, Professor Ivkov's research encompasses physics, biology, chemistry, and engineering, making him ideally placed to lead a journal that highlights the convergence of different disciplines to tackle cancer.
Professor Ivkov co-founded a start-up biotechnology company and worked for many years developing antibody-labelled magnetic iron oxide nanoparticles as a thermal ablation tool for breast cancer. In early 2008, the company underwent a merger, and he joined the faculty at the Johns Hopkins University School of Medicine.
Professor Ivkov's current research focuses specifically on the development and characterisation of magnetic nanostructured materials and devices for cancer therapy; and, most recently on how these interact with the complex biology and immunology of cancer.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
